Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 22;39(15):e136.
doi: 10.3346/jkms.2024.39.e136.

Characterization of Ceftriaxone-Resistant Haemophilus influenzae Among Korean Children

Affiliations

Characterization of Ceftriaxone-Resistant Haemophilus influenzae Among Korean Children

Sanghoon Lee et al. J Korean Med Sci. .

Abstract

Background: Haemophilus influenzae is a frequently encountered pathogen responsible for respiratory tract infections in children. Following the detection of ceftriaxone-resistant H. influenzae at our institution, we aimed to investigate the resistance mechanisms of ceftriaxone in H. influenzae, with a particular focus on alterations in penicillin-binding protein 3 (PBP3) and β-lactamase production.

Methods: Among H. influenzae isolates collected at Asan Medical Center Children's Hospital from March 2014 to April 2019, ceftriaxone-resistant strains by the disk-diffusion test were included. Ceftriaxone minimum inhibitory concentrations (MICs) were determined using the E-test according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. The presence of β-lactamase was assessed through cefinase test and TEM-1/ROB-1 polymerase chain reaction (PCR). PBP3 alterations were explored via ftsI gene sequencing.

Results: Out of the 68 collected strains, 21 exhibited resistance to ceftriaxone in disk diffusion tests. Two strains were excluded due to failed subculture. Among 19 ceftriaxone-resistant H. influenzae isolates, eighteen were non-typeable H. influenzae, and twelve were positive for TEM-1 PCR. Isolates were classified into groups II (harboring only N526K, n = 3), III (N526K+S385T, n = 2), III+ (S385T+L389F+N526K, n = 11), and III-like+ (S385T+L389F+R517H, n = 3) according to the PBP3 alteration pattern. With a median ceftriaxone MIC of 0.190 mg/L (range, 0.008-0.750), the median ceftriaxone MIC was the highest in group III-like+ (0.250 mg/L), followed by groups III+ (0.190 mg/L), III (0.158 mg/L), and II (0.012 mg/L). All three strains belonging to group II, which did not harbor the S385T substitution, had ceftriaxone MICs of ≤ 0.125 mg/L.

Conclusion: The emergence of ceftriaxone-resistant H. influenzae with ceftriaxone MIC values of up to 0.75 mg/L was observed even in children in South Korea, with most associated with S385T and L389F substitutions. The N526K mutation alone does not significantly impact ceftriaxone resistance. Further large-scale studies are essential to investigate changes in antibiotic resistance patterns and factors influencing antibiotic resistance in H. influenzae isolated from pediatric patients in Korea.

Keywords: Ceftriaxone Resistance; Haemophilus influenzae; Penicillin-binding Protein 3 Alteration.

PubMed Disclaimer

Conflict of interest statement

The authors have no potential conflicts of interest to disclose.

Figures

Fig. 1
Fig. 1. This scatterplot and table illustrate the variations in ceftriaxone MIC among different groups based on the amino acid substitution in PBP3 of the isolates. Isolates with the same amino acid substitution are grouped together in both the graph and table. The table indicates the group numbers and their corresponding amino acid substitutions. The median values are represented by horizontal lines across the plots.
MIC = minimum inhibitory concentration, PBP3 = penicillin-binding protein 3, F = phenylalanine, H = histidine, K = lysine, L = leucine, N = asparagine, R = arginine, S = serine, T = threonine.

References

    1. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae . Clin Microbiol Rev. 2007;20(2):368–389. - PMC - PubMed
    1. Langereis JD, de Jonge MI. Invasive disease caused by Nontypeable Haemophilus influenzae . Emerg Infect Dis. 2015;21(10):1711–1718. - PMC - PubMed
    1. Kim JS, Jang YT, Kim JD, Park TH, Park JM, Kilgore PE, et al. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children. Vaccine. 2004;22(29-30):3952–3962. - PubMed
    1. Wang S, Tafalla M, Hanssens L, Dolhain J. A review of Haemophilus influenzae disease in Europe from 2000-2014: challenges, successes and the contribution of hexavalent combination vaccines. Expert Rev Vaccines. 2017;16(11):1095–1105. - PubMed
    1. Gilsdorf JR. Hib vaccines: their impact on Haemophilus influenzae Type b disease. J Infect Dis. 2021;224(12) Suppl 2:S321–S330. - PMC - PubMed

MeSH terms